Insights from 2023 ASCO® Annual Meeting
ASCO® 2023 Insights: "A Phase 2 Basket Study of Tucatinib & Trastuzumab for Previously Treated HER2+ Metastatic Biliary Tract Cancer (SGNTUC-019)"
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Yoshiaki Nakamura
By
Insights from 2023 ASCO® Annual Meeting
FEATURING
Yoshiaki Nakamura
Login to view comments.
Click here to Login